Last reviewed · How we verify
EMLA Analgesic Cream
At a glance
| Generic name | EMLA Analgesic Cream |
|---|---|
| Sponsor | Hillel Yaffe Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Evaluation of Paro, a Therapeutic Assistance Robot in Analgesic Management During the Placement of a Peripheral Intravenous Line in Infants and Children. (NA)
- Topical Anesthesia During Catheter Insertion for Cervical Ripening (TOLERANCE) (PHASE4)
- Impact of Virtual Reality in Hematology and Oncology During Invasive Procedures in Children, Adolescents and Young Adults, from 7 to Less Than 25 Years Old (NA)
- EMLA Cream as Analgesic for Outpatient Gynecological Procedures (PHASE4)
- Contribution of Hypnosis During a Lumbar Puncture. (NA)
- Simultaneous Versus Sequential Fractional CO2 Laser and Subcision Combination for Post-acne Atrophic Scars: A Split-face Comparative Study. (NA)
- The Effect of Combined Oral and Topical Analgesics to Reduce Pain Perception During Electrodiagnostic Testing (NA)
- Developing an Objective Measure of Experienced Pain (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- EMLA Analgesic Cream CI brief — competitive landscape report
- EMLA Analgesic Cream updates RSS · CI watch RSS
- Hillel Yaffe Medical Center portfolio CI